Expression of GPC3 protein and its significance in lung squamous cell carcinoma

被引:34
|
作者
Lin, Qiang [1 ]
Xiong, Li-wen [2 ]
Pan, Xu-feng [1 ]
Gen, Jun-feng [1 ]
Bao, Guo-liang [3 ]
Sha, Hui-fang [3 ]
Feng, Jiu-xian [3 ]
Ji, Chun-yu [1 ]
Chen, Ming [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Lung Canc Inst, Shanghai 200030, Peoples R China
关键词
GPC3; Lung squamous cell carcinoma; RT-PCR; Western blot; BEHMEL OVERGROWTH SYNDROME; GLYPICAN-3; EXPRESSION; HEPATOCELLULAR-CARCINOMA; MICROARRAY ANALYSIS; TUMOR SUPPRESSOR; BREAST-CANCER; GENE; MARKER; ADENOCARCINOMA; MELANOMA;
D O I
10.1007/s12032-011-9973-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to investigate GPC3 gene expression in lung squamous cell carcinoma tissue and its correlation with clinical and tumor characteristics. Using RT-PCR, the presence of GPC3 gene expression was detected in cancer tissue and adjacent normal tissue in 66 cases of lung squamous cell carcinoma and positive rates were calculated. Using Western blot, changes in GPC3 protein expression were detected in lung squamous cell carcinoma and adjacent normal tissues. The percentage of tissue samples expressing GPC3 mRNA was significantly higher in lung squamous cell carcinoma than in adjacent normal tissue (P < 0.05). This percentage was also significantly higher for cases with lymph node metastasis than for those without lymph node metastasis (P < 0.05). Further, the percentage of samples expressing GPC3 mRNA was higher with lowering degrees of tumor differentiation (P < 0.05). Rates of GPC3 expression were, however, independent of patient gender, age, and tumor size (P > 0.05). The expression of GPC3 protein in lung squamous cell carcinoma was significantly higher than that in adjacent normal tissues (P < 0.05). The expression in cases with lymph node metastasis was significantly higher than in those without lymph node metastasis (P < 0.05), and GPC3 protein expression increased with lowering degrees of tumor differentiation (P < 0.05). Further investigation is warranted for the association of initiation, development, invasion, and metastasis of disease.
引用
收藏
页码:663 / 669
页数:7
相关论文
共 50 条
  • [1] Expression of GPC3 protein and its significance in lung squamous cell carcinoma
    Qiang Lin
    Li-wen Xiong
    Xu-feng Pan
    Jun-feng Gen
    Guo-liang Bao
    Hui-fang Sha
    Jiu-xian Feng
    Chun-yu Ji
    Ming Chen
    Medical Oncology, 2012, 29 : 663 - 669
  • [2] Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance
    Yu, X.
    Li, Y.
    Chen, S. W.
    Shi, Y.
    Xu, F.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 10185 - 10192
  • [3] GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
    Jing Ning
    Shenyi Jiang
    Xiaoxi Li
    Yang Wang
    Xuhong Deng
    Zhiqiang Zhang
    Lijie He
    Daqing Wang
    Youhong Jiang
    BMC Pulmonary Medicine, 21
  • [4] GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
    Ning, Jing
    Jiang, Shenyi
    Li, Xiaoxi
    Wang, Yang
    Deng, Xuhong
    Zhang, Zhiqiang
    He, Lijie
    Wang, Daqing
    Jiang, Youhong
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [5] Research Status and Progress on the Relationship between GPC3 and Lung Squamous Cell Carcinoma
    Ning, Jing
    Jiang, Shenyi
    Wang, Shu
    Deng, Xuhong
    Zhang, Zhiqiang
    He, Lijie
    Wang, Daqing
    Jiang, Youhong
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (06): : 1735 - 1740
  • [6] GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells
    Ning, Jing
    Ding, Jianqiao
    Wang, Shu
    Jiang, Youhong
    Wang, Daqing
    Jiang, Shenyi
    JOURNAL OF IMMUNOLOGY RESEARCH, 2023, 2023
  • [7] Glypican-1,-3,-5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma
    Schlaepfer Sales, Caroline B.
    Guimaraes, Vanessa S. N.
    Valverde, Ludmila F.
    Dias, Rosane B.
    Freitas, Raiza D.
    Siquara da Rocha, Leonardo de Oliveira
    de Miranda, Malu Coelho
    Boas, Deise S. Vilas
    Goncalves Agra, Ivan M.
    dos Santos, Jean N.
    Gurgel Rocha, Clarissa A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (05) : 345 - 351
  • [8] An Assessment of the Heterogeneous Expression of Glypican-3 (GPC3) in Hepatocellular Carcinoma (HCC) in the Era of GPC3 as a Biomarker
    Cox, Brian
    Waters, Kevin
    Dhall, Deepti
    Larson, Brent
    Guindi, Maha
    LABORATORY INVESTIGATION, 2019, 99
  • [9] An Assessment of the Heterogeneous Expression of Glypican-3 (GPC3) in Hepatocellular Carcinoma (HCC) in the Era of GPC3 as a Biomarker
    Cox, Brian
    Waters, Kevin
    Dhall, Deepti
    Larson, Brent
    Guindi, Maha
    MODERN PATHOLOGY, 2019, 32
  • [10] Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance
    Guo, Feng
    Hiroshima, Kenzo
    Wu, Di
    Satoh, Mamoru
    Abulazi, Mayinuer
    Yoshino, Ichiro
    Tomonaga, Takeshi
    Nomura, Fumio
    Nakatani, Yukio
    HUMAN PATHOLOGY, 2012, 43 (08) : 1282 - 1288